Skip to main content

Table 2 Diagnostic value of HA in MPM

From: CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives

Function

Method/specimen

Reference

HA is associated with malignant tumor of the pleura

Enzymatic analysis/pleural fluid

Meyer and Chaffee. 1940 [85]

HA proposed as a diagnostic tool

Electrophoresis/Pleural fluids

Boersma et al. 1975 [91]

HA as a major GAG confirms MPM diagnosis

Electrophoresis/MPM and other tumor tissues

Waxler et al. 1979 [94]

High HA is a clinical finding in MPM

GAG-degrading enzyme assay/pleural tissues

Arai et al. 1979 [36]

Increased total GAG aids in differential diagnosis between diffuse MPM and ADC

IHC/MPM tissues

Kawai et al. 1985 [95]

HA indicates diffuse MPM

Colorimetric assay/pleural fluids

Matzel and Schubert. 1979 [93]

HA aids in differential diagnosis between MPM and primary ADC

Electrophoresis/MPM and other tumor tissues

Chiu et al. 1984 [87]

Increased HA level is associated with tumor damage

IHC/pleural effusions

Thylen et al. 1999 [88]

Dahl et al. 1989 [35]

HA is an indicator for MPM

HPLC/pleural and peritoneal effusions

Roboz et al. 1985 [86]

Increased serum HA indicates progressive MPM

Radiometric assay/patient serum

Frebourg et al. 1987 [34]

Dahl et al. 1984

Thylen et al. 1994

HA and chondroitin sulfate are basic features of MPM

IHC/tumor tissues and pleural fluids

Nakano et al. 1986 [96]

Positive HA staining highly predictive of MPM

HA-binding probe/MPM and ADC tissues

Azumi et al. 1992 [90]

Presence of HA distinguishes MPM from ADC

IHC, HPLC/pleural effusion and tumor tissues

Klominek et al. 1989 [89]

Attanoos et al. 1997 [80]

High HA with CEA aid in differential diagnosis of MPM

Radiometric assay/Pleural fluids and patient serum

Atagi et al. 1997 [92]

Pettersson et al. 1988 [33]

Increased HA-binding in pleural effusion cells serves as additional diagnostic marker

[3H] hyaluronate binding assay/primary cell cultures

Teder et al. 1996 [99]

High intracellular HA delineates MPM from ADC

IHC/serous fluids

Afify et al. 2005 [81]

Increased HA level is not specific for MPM diagnosis

ELISA assay/Pleural effusions and serum

Hillerdal et al. 1991 [98]

Combination of HA and cytology may improve diagnosis of MPM

Immunoassay and IHC/pleural effusions

Welker et al. 2007 [97]

HA >100 000 ng/ml recommended as diagnostic indicator for MPM

ELISA assay pleural fluids of MPM and other tumors

Fujimoto et al. 2013 [31]

High HA is associated with MPM

IHC/MPM tissues

Töronnen et al. 2016 [83]

  1. MPM malignant pleural mesothelioma, ADC adenocarcinoma, HA hyaluronic acid, GAG glycosaminoglycan, IHC immunohistochemistry, ELISA enzyme-linked immunosorbent assay, HPLC high pressure liquid chromatography